首页> 外文期刊>Der Hautarzt; Zeitschrift fuer Dermatologie, Venerologie, und verwandte Gebiete >[Assessment of pruritus - current standards and implications for clinical practice : Consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)].
【24h】

[Assessment of pruritus - current standards and implications for clinical practice : Consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)].

机译:[瘙痒评估-当前标准及其对临床实践的意义:国际瘙痒研究工作组(AGP)行动小组瘙痒参数共识文件]。

获取原文
获取原文并翻译 | 示例
           

摘要

With a prevalence of 20%, chronic pruritus is a symptom of many diseases with major impact on healthcare costs. The lack of specific therapeutic measures makes the development of new drugs and their testing in clinical trials urgent. It is not possible to measure pruritus in an objective way. For these reasons, it is necessary to have a series of standardized measures to characterize pruritus in a reliable way. Intensity scales such as the visual analog scale (VAS) are most frequently used to document the course of the symptoms. However, for assessing pruritus intensity, VAS is not an optimal instrument, although it cannot be dispensed with. The VAS should be combined with other scales in clinical studies in order to internally test the consistency of data. Other instruments for assessing intensity and course of pruritus are in the process of development. Presently scratch activity and scratch-associated lesions can be documented in a descriptive fashion. There are some studies that have employed devices to document scratch activity; however, methodological studies are not yet available. The patient-benefit index is an indispensable tool in clinical trials. A questionnaire for gathering data on the history and some pruritus-specific parameters has been developed and published. Questionnaires on patient quality of life, anxiety and depression are helpful in obtaining data on other cost-relevant parameters. A questionnaire on the quality of life, for instance, can provide important help in the assessment of the burden of the disease. The results of these questionnaires can be correlated with data on pruritus intensity scales. The relevant questionnaires have been partially digitalized so that they are available immediately as part of patient care. Additional methodological developments and studies are required in order to define a robust set of instruments for measuring pruritus in daily practice and in clinical studies.
机译:慢性瘙痒症的患病率为20%,是许多疾病的症状,对医疗保健成本产生重大影响。缺乏具体的治疗措施使得新药的开发及其在临床试验中的测试变得迫在眉睫。不可能客观地测量瘙痒。由于这些原因,有必要采取一系列标准化措施以可靠的方式表征瘙痒。诸如视觉模拟量表(VAS)之类的强度量表最常用于记录症状的过程。但是,对于评估瘙痒强度,VAS虽然不是必须的,但却不是最佳的工具。 VAS应该在临床研究中与其他量表结合使用,以便在内部测试数据的一致性。其他评估瘙痒强度和病程的工具正在开发中。目前,可以以描述性方式记录刮擦活动和与刮擦相关的病变。有一些研究采用了记录划痕活动的设备。但是,尚无方法学研究。患者受益指数是临床试验中必不可少的工具。收集并收集了有关历史和某些瘙痒特定参数的数据调查表。有关患者生活质量,焦虑和抑郁的问卷调查有助于获得有关其他与费用相关的参数的数据。例如,有关生活质量的调查表可以在评估疾病负担方面提供重要帮助。这些问卷的结果可以与瘙痒强度量表的数据相关。相关问卷已部分数字化,因此可以作为患者护理的一部分立即使用。为了定义一套强大的工具来测量日常实践和临床研究中的瘙痒,还需要进行其他方法学研究和开发。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号